Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Le Forestier

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Revue Neurologique|October 17, 1998
[Pure motor neuropathy after radiation therapy: 6 cases]T Lalu, B Mercier, N Birouk, et al.
Journal of the Neurological Sciences|April 20, 2001
Primary lateral sclerosis: further clarificationN Le Forestier, T Maisonobe, L Spelle, et al.
Revue Neurologique|May 5, 2000
[What's new in primary lateral sclerosis?]N Le Forestier, T Maisonobe, L Spelle, et al.
Revue Neurologique|June 20, 2002
[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival]R Velasco, F Salachas, E Munerati, et al.
Annales De Biologie Clinique|December 16, 2003
[Difficult diagnosis of autoimmune peripheral neuropathy]L Limousin, J Neil, N Le Forestier, et al.
Revue Neurologique|July 13, 2020
Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral SclerosisM Mongin, R Debs, N Le Forestier, et al.
Supplements to Clinical Neurophysiology|August 19, 2010
Motor neuron disorders: novel electrophysiologic approach (MUFDEC protocol)F C Wang, N Le Forestier, P Gérard, et al.
Brain : a Journal of Neurology|September 26, 2001
Does primary lateral sclerosis exist? A study of 20 patients and a review of the literatureN Le Forestier, T Maisonobe, A Piquard, et al.
Neurology|April 10, 2002
APOE: a potential marker of disease progression in ALSL Lacomblez, V Doppler, I Beucler, et al.
Brain : a Journal of Neurology|May 1, 1997
Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 casesN Birouk, R Gouider, E Le Guern, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Revue Neurologique|October 17, 1998
[Pure motor neuropathy after radiation therapy: 6 cases]T Lalu, B Mercier, N Birouk, et al.
Journal of the Neurological Sciences|April 20, 2001
Primary lateral sclerosis: further clarificationN Le Forestier, T Maisonobe, L Spelle, et al.
Revue Neurologique|May 5, 2000
[What's new in primary lateral sclerosis?]N Le Forestier, T Maisonobe, L Spelle, et al.
Revue Neurologique|June 20, 2002
[Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival]R Velasco, F Salachas, E Munerati, et al.
Annales De Biologie Clinique|December 16, 2003
[Difficult diagnosis of autoimmune peripheral neuropathy]L Limousin, J Neil, N Le Forestier, et al.
Revue Neurologique|July 13, 2020
Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral SclerosisM Mongin, R Debs, N Le Forestier, et al.
Supplements to Clinical Neurophysiology|August 19, 2010
Motor neuron disorders: novel electrophysiologic approach (MUFDEC protocol)F C Wang, N Le Forestier, P Gérard, et al.
Brain : a Journal of Neurology|September 26, 2001
Does primary lateral sclerosis exist? A study of 20 patients and a review of the literatureN Le Forestier, T Maisonobe, A Piquard, et al.
Neurology|April 10, 2002
APOE: a potential marker of disease progression in ALSL Lacomblez, V Doppler, I Beucler, et al.
Brain : a Journal of Neurology|May 1, 1997
Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 casesN Birouk, R Gouider, E Le Guern, et al.
Pageof 4